Inclusion, Diversity, Equity, Anti-racism, & Social Justice

IDEAS Podcasts

Check out the most recent IDEAS-related podcast!

Availability of Lomustine for Glioblastoma Multiforme

Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.

Listen to a curated selection of Neurology Podcasts on IDEAS content, chosen by Neurology IDEAS Section Editor, Joshua A. Budhu, MD, MS. [Listen now]

Taking a Stand

New & Notable

July 21, 2022

• Imposter syndrome describes “high-achieving individuals who, despite objective successes, fail to internalize their accomplishments and have persistent self-doubt and fear of being exposed as a fraud or impostor.”
  Reference:
  DM Bravata, SA Watts, AL Keefer, et al. Prevalence, Predictors, and Treatment of Impostor Syndrome: a Systematic Review. J Gen Intern Med 2019;35(4):1252-1275. DOI: 10.1007/s11606-019-05364-1.
   
• Imposter syndrome is not a defined psychiatric disorder but is a popular lay term. It was first described by woman psychologists Pauline Clance and Suzanne Imes in 1978, who used this term to describe their experiences as graduate students. The authors gathered information from interactions with over 150 highly successful women who despite their achievements did not experience an internal sense of success.
  References:
  Diana Opong. < 5 Steps To Shake The Feeling That You're An Impostor. 2021. Accessed June 23, 2022. https://www.npr.org/transcripts/959656202.
  PR Clance and SA Imes. The Imposter Phenomenon in High Achieving Women: Dynamics and Therapeutic Intervention. https://doi.org/10.1037/h0086006
   
• In a systematic review by Bravata et al. in 2019, prevalence rates of impostor syndrome varied widely from 9 to 82% largely depending on the screening tool and cutoff used to assess symptoms. Of thirty-three articles comparing the rates of imposter syndrome by gender, sixteen showed that women reported statistically significantly higher rates of impostor feelings than men compared to seventeen studies that showed no difference.
  Reference:
  DM Bravata, SA Watts, AL Keefer, et al. Prevalence, Predictors, and Treatment of Impostor Syndrome: a Systematic Review. 2019;35(4):1252-1275. DOI: 10.1007/s11606-019-05364-1.
   
• Stereotype threat is a situational threat that occurs when individuals underperform due to a conscious or unconscious fear of being evaluated through the lens of negative stereotypes that may affect those individuals. Stereotype threat can affect both healthcare providers and patients and may significantly contribute to differences in healthcare outcomes.
  References:
  CM Steele. A threat in the air: How stereotypes shape intellectual identity and performance. American Psychologist 1997;52(6):613–629. https://doi.org/10.1037/0003-066X.52.6.613.
  CM Abdou, AW Fingerhut, JS Jackson, F Wheaton. Healthcare Stereotype Threat in Older Adults in the Health and Retirement Study. Am J Prev Med 2016;50(2):191–198. https://doi.org/10.1016/j.amepre.2015.07.034.
   
• Between 2011 to 2019, people who identify as women, Asians/Pacific Islanders, and African Americans in neurology residency programs increased. Hispanic/Latino and American Indian/Alaska Native residents did not increase and made up 5.2% and 0.23% respectively of residents across the nation. The diversity in race and ethnicity amongst neurology residents lags relative to US medical students and population.
  Reference:
  Fabiola Valenzuela, Minerva A. Romero Arenas. An Assessment of Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians. 2021;96(15 Supplement):4918.